FDA advisory board supports implant that suppresses appetite

An FDA advisory committee on Tuesday said EnteroMedics' Maestro Rechargeable System, designed to suppress appetite and calorie absorption through electrical stimulation of intra-abdominal vagus nerve trunks, is safe and its benefits outweigh the risks. However, the panel was split on whether the ...

Share

This news summary appeared in DiabetesPro SmartBrief on 06/18/2014
Click here to view the full issue.


View the original article:
HealthDay News

Want to see more news summaries?
Sign up for DiabetesPro SmartBrief

DiabetesPro SmartBrief is a FREE, daily email newsletter that summarizes the day's top industry news from hundreds of sources. Each day, subscribers receive 8-10 headlines and news summaries like the one to the left
Sign up:
About SmartBrief
SmartBrief is the leading online publisher of targeted business news and information by industry. By combining technology and editorial expertise, SmartBrief filters thousands of sources daily to deliver the most relevant industry news in partnership with more than 180 trade associations, professional societies nonprofits and corporate entities